PharmAsia News Notable Notes: Citigroup Reiterates Buy On India’s Sun Pharma

NEW DELHI - Citigroup Global Markets reiterated its buy on Sun Pharma, India's largest drug company by market capitalization, saying a recent price dip related to a disputed merger attempt with Israel's Taro Pharma offers a "window of opportunity.

More from Archive

More from Scrip